Collaborate to identify and resolve drug-related problems
An Australian study indicates pharmacists should play a larger role in identifying and resolving drug-related problems (DRPs) as part of a collaborative general practice...
Budget supports general practice pharmacists
Greater support for GP pharmacists, funds for high-cost medicine reduction and $1 billion for new PBS spending have emerged as the high points of...
Opioid replacement therapy – supporting treatment
Drug dependence, including opioid dependence, involves a complex interplay of social, psychological and biological factors.
Learning objectives
After reading this article, pharmacists should be able...
What we know about giving Aussie kids a healthy head start
Unpredictable eating habits in kids is a problem facing many Australian parents, every day.
‘Don’t you know who I am?’: Why patient identification is so...
When we think patient safety, pharmacists’ minds jump to drug interactions, adverse events or toxic doses. But incorrect patient identification can have equal capacity...
Medicinal cannabis goes mainstream, but safety concerns are growing
Once considered a fringe therapy, medicinal cannabis is rapidly becoming a mainstream prescribing option. As demand surges, pharmacists are left managing clinical risks and patient expectations while regulators struggle to keep up. But is this starting to change?
